Login / Signup

Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.

Ana Merino-RibasRicardo AraujoIoana BancuFredzzia GraterolAndrea VergaraMarc Noguera-JulianRoger ParedesJordi BonalBenedita Sampaio-Maia
Published in: International urology and nephrology (2021)
These results suggest that a 5-month treatment with either calcium acetate or sucroferric oxyhydroxide did not modify baseline diversity or baseline bacterial composition in hemodialysis patients, also about the high-variability profiles of the gut microbiome found among these patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • patient reported outcomes
  • smoking cessation